Sector Gamma AS Buys 53,000 Shares of Bruker Corporation $BRKR

Key Points

• Sector Gamma AS increased its stake in Bruker Corporation by 33.3%, holding approximately $8.85 million worth of shares as of the latest filing.
• Bruker reported a 2.6% decline in stock price with Q2 earnings missing estimates, posting $0.32 EPS against an anticipated $0.33.
• The company announced a quarterly dividend of $0.05 per share, reflecting a 0.6% dividend yield for shareholders, payable on October 3rd.

Sector Gamma AS boosted its position in Bruker Corporation (NASDAQ:BRKR - Free Report) by 33.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 211,970 shares of the medical research company's stock after buying an additional 53,000 shares during the quarter. Bruker makes up about 2.8% of Sector Gamma AS's investment portfolio, making the stock its 16th biggest holding. Sector Gamma AS owned approximately 0.14% of Bruker worth $8,848,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of BRKR. Teacher Retirement System of Texas grew its stake in Bruker by 5.1% during the 1st quarter. Teacher Retirement System of Texas now owns 29,045 shares of the medical research company's stock worth $1,212,000 after buying an additional 1,422 shares during the last quarter. Fifth Third Bancorp boosted its holdings in shares of Bruker by 54.2% in the first quarter. Fifth Third Bancorp now owns 1,109 shares of the medical research company's stock valued at $46,000 after acquiring an additional 390 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its position in shares of Bruker by 81.2% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 29,826 shares of the medical research company's stock valued at $1,245,000 after purchasing an additional 13,367 shares during the period. OneDigital Investment Advisors LLC raised its position in Bruker by 38.0% in the first quarter. OneDigital Investment Advisors LLC now owns 5,522 shares of the medical research company's stock worth $230,000 after acquiring an additional 1,520 shares in the last quarter. Finally, Sterling Capital Management LLC lifted its stake in Bruker by 29.0% during the fourth quarter. Sterling Capital Management LLC now owns 3,514 shares of the medical research company's stock valued at $206,000 after purchasing an additional 791 shares during the last quarter. Institutional investors own 79.52% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the company. The Goldman Sachs Group decreased their price target on Bruker from $50.00 to $45.00 and set a "neutral" rating for the company in a research report on Thursday, May 8th. Citigroup decreased their price objective on shares of Bruker from $40.00 to $38.00 and set a "neutral" rating for the company in a research note on Monday, August 4th. UBS Group lowered their price objective on shares of Bruker from $57.00 to $45.00 and set a "neutral" rating on the stock in a research report on Thursday, May 8th. Wells Fargo & Company reduced their target price on Bruker from $60.00 to $50.00 and set an "overweight" rating for the company in a report on Tuesday, August 5th. Finally, Stifel Nicolaus set a $40.00 price target on Bruker and gave the company a "hold" rating in a report on Tuesday, August 5th. Five investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $51.30.

Insider Activity at Bruker

In other Bruker news, CEO Frank H. Laukien bought 2,608 shares of the stock in a transaction dated Friday, June 6th. The stock was bought at an average cost of $38.36 per share, for a total transaction of $100,042.88. Following the completion of the purchase, the chief executive officer owned 38,462,171 shares in the company, valued at $1,475,408,879.56. This represents a 0.01% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 27.30% of the company's stock.

Bruker Stock Performance

Shares of NASDAQ BRKR traded up $0.60 during trading hours on Tuesday, hitting $34.84. 2,825,969 shares of the stock were exchanged, compared to its average volume of 2,456,627. Bruker Corporation has a one year low of $30.00 and a one year high of $72.94. The company has a debt-to-equity ratio of 1.31, a current ratio of 1.61 and a quick ratio of 0.70. The firm has a market capitalization of $5.29 billion, a P/E ratio of 67.00, a P/E/G ratio of 2.77 and a beta of 1.16. The company's 50 day moving average is $38.89 and its 200 day moving average is $41.45.

Bruker (NASDAQ:BRKR - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The medical research company reported $0.32 earnings per share for the quarter, missing analysts' consensus estimates of $0.33 by ($0.01). The company had revenue of $797.40 million during the quarter, compared to the consensus estimate of $811.17 million. Bruker had a net margin of 2.31% and a return on equity of 17.89%. Bruker's revenue for the quarter was down .4% on a year-over-year basis. During the same period last year, the company earned $0.52 earnings per share. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. On average, research analysts expect that Bruker Corporation will post 2.69 EPS for the current year.

Bruker Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 3rd. Stockholders of record on Tuesday, September 23rd will be paid a $0.05 dividend. This represents a $0.20 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Tuesday, September 23rd. Bruker's payout ratio is currently 38.46%.

Bruker Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.